Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new medication called RGT001-075 to help overweight individuals lose weight. Participants will be randomly assigned to receive either RGT001-075 or a placebo for 12 weeks
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the clinical trial allowing participation of individuals older than 45 years?
"Individuals over 18 years and under the age of 75 are eligible for enrollment in this study."
Has the RGT001-075 Group received approval from the FDA?
"Based on the phase 2 trial status of RGT001-075 Group, it has been assigned a safety rating of 2 by our team at Power."
In how many distinct clinics is this experimental investigation currently being conducted?
"At the moment, patient enrollment is ongoing at 10 different sites. These include Medford, East Greenwich, Valparaiso, and several other undisclosed locations. Opting for the closest site to your residence will reduce travel burdens upon participation in this trial."
What is the current number of individuals being selected to participate in this clinical investigation?
"Indeed, the information on clinicaltrials.gov shows that this trial is actively seeking volunteers. The initial posting of this medical study was on March 8th, 2024, and its latest update occurred on April 2nd, 2024. A total of 60 participants are being sought across ten different sites."
Are there any available positions for patients to participate in this clinical trial?
"According to the details on clinicaltrials.gov, this research is currently in need of participants. The trial was publicly listed on March 8th, 2024 and underwent its most recent revision on April 2nd, 2024."
Which specific criteria must individuals meet in order to be considered suitable candidates for enrollment in this medical study?
"To be considered for enrollment in this research, individuals aged 18 to 75 with a body mass index (BMI) ranging from 27 kg/m² to 45 kg/m² and maintaining consistent weight levels over the previous three months are eligible."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger